BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21492190)

  • 1. Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.
    Wearn JM; Crisman MV; Davis JL; Geor RJ; Hodgson DR; Suagee JK; Ashraf-Khorassani M; McCutcheon LJ
    J Vet Pharmacol Ther; 2011 Jun; 34(3):252-8. PubMed ID: 21492190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of pioglitazone in lean and obese cats.
    Clark MH; Hoenig M; Ferguson DC; Dirikolu L
    J Vet Pharmacol Ther; 2012 Oct; 35(5):428-36. PubMed ID: 22612529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
    Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
    Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence study of 30 mg pioglitazone tablets in Thai healthy volunteers.
    Chatsiricharoenkul S; Pongnarin P; Sathirakul K; Kongpattanakul S
    J Med Assoc Thai; 2007 Mar; 90(3):564-8. PubMed ID: 17427536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.
    Christensen ML; Meibohm B; Capparelli EV; Velasquez-Mieyer P; Burghen GA; Tamborlane WV
    J Clin Pharmacol; 2005 Oct; 45(10):1137-44. PubMed ID: 16172178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
    Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
    Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
    Davis JL; Papich MG; Weingarten A
    J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of potassium bromide in adult horses.
    Raidal SL; Edwards S
    Aust Vet J; 2008 May; 86(5):187-93. PubMed ID: 18454837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of metformin in horses.
    Hustace JL; Firshman AM; Mata JE
    Am J Vet Res; 2009 May; 70(5):665-8. PubMed ID: 19405907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a low dose and FDA-labeled dose of diclazuril administered orally as a pelleted topdressing in adult horses.
    Hunyadi L; Papich MG; Pusterla N
    J Vet Pharmacol Ther; 2015 Jun; 38(3):243-8. PubMed ID: 25329774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
    Choi JS; Koh YY; Chung JH; Choi DH; Han HK
    J Pharm Pharmacol; 2008 Oct; 60(10):1403-7. PubMed ID: 18812034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and pharmacokinetics of tetrahydrogestrinone in horses.
    Machnik M; Gerlach M; Kietzmann M; Niedorf F; Thevis M; Schenk I; Guddat S; Düe M; Schänzer W
    J Vet Pharmacol Ther; 2009 Apr; 32(2):197-202. PubMed ID: 19290951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of firocoxib after administration of multiple consecutive daily doses to horses.
    Letendre LT; Tessman RK; McClure SR; Kvaternick VJ; Fischer JB; Hanson PD
    Am J Vet Res; 2008 Nov; 69(11):1399-405. PubMed ID: 18980421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.
    Cox S; Villarino N; Sommardahl C; Kvaternick V; Zarabadipour C; Siger L; Yarbrough J; Amicucci A; Reed K; Breeding D; Doherty T
    Vet J; 2013 Nov; 198(2):382-5. PubMed ID: 24076125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.